Related Experiment Video

Updated: Aug 9, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Coronary stenting and inflammation: implications for further surgical and medical treatment

Walter J Gomes1, Enio Buffolo

  • 1Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil. wjgomes.dcir@epm.br

The Annals of Thoracic Surgery
|April 25, 2006
PubMed

Insights

Percutaneous coronary interventions (PCI) may cause inflammation, potentially impacting future treatments like coronary artery bypass graft surgery and medical therapies. Further research is needed to assess these long-term effects on patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Surgical Innovation

Background:

  • Percutaneous coronary interventions (PCI) with stent implantation are standard for coronary artery disease (CAD).
  • Current treatment pathways often involve PCI followed by coronary artery bypass graft (CABG) surgery if PCI fails.
  • Emerging evidence suggests chronic inflammation and endothelial dysfunction post-PCI.

Purpose of the Study:

  • To examine the clinical significance of post-PCI complications.
  • To assess the impact of PCI-induced inflammation on subsequent treatments.
  • To evaluate the potential adverse effects on CABG graft patency and medical therapy efficacy.

Main Methods:

  • Review of existing literature on PCI complications.
  • Analysis of studies investigating inflammatory markers after PCI.
  • Examination of outcomes in patients undergoing subsequent CABG or medical treatment after PCI.

Main Results:

  • PCI may induce chronic inflammatory reactions and endothelial dysfunction.
  • These complications could negatively affect outcomes of subsequent CABG surgery.
  • The efficacy of medical treatments may be diminished in patients with prior PCI.

Conclusions:

  • The long-term clinical significance of post-PCI complications requires further investigation.
  • PCI-induced inflammation may compromise the success of future cardiovascular interventions.
  • Current assumptions about the safety of CABG after PCI failure may need re-evaluation.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...